Advertisement

Management of patients with ≥4 brain metastases using stereotactic radiosurgery boost after whole brain irradiation

Abstract

Aims and background. Brain metastases are a prevalent consequence of systemic cancer, and patients suffering from brain metastases usually present with multiple metastatic lesions. An overwhelming majority of the available literature assessing the role of stereotactic radiosurgery in brain metastasis management includes patients with up to 4 metastases. Given the significant benefit of stereotactic radiosurgery for the treatment of 1 to 3 brain metastases, we evaluated the use of stereotactic radiosurgery boost after whole brain irradiation in the management of patients with ≥4 brain metastases.
Methods. In this retrospective analysis, outcomes of 50 patients who underwent linear accelerator-based stereotactic radiosurgery boost within 4 to 6 weeks of whole brain irradiation for ≥4 brain metastases were assessed in terms of local control, overall survival, primary involved organ, recursive partitioning analysis class and Karnofsky performance status at the time of stereotactic radiosurgery, number of lesions, age, status of the primary cancer (controlled vs uncontrolled), presence of extracranial disease and toxicity.
Results. Fifty patients with ≥4 brain metastases were treated using linear acceleratorbased stereotactic radiosurgery boost after whole brain irradiation between April 1998 and April 2013. Mean and median number of intracranial lesions was 6.02 and 6, respectively. Median lesion volume was 10.9 cc (range, 0.05-32.6). Median survival time after radiosurgery was 10.1 months (range, 1-25). Status of the primary cancer (controlled vs uncontrolled), recursive partitioning analysis class, Karnofsky performance status, and extracranial metastasis showed statistically significant correlations with overall survival (P >0.001). Treatment-related side effects after stereotactic radiosurgery included temporary edema (n = 14, 28%), hemiparesis (n = 1, 2%), seizure (n = 1, 2%), leukoencephalopathy (n = 2, 4%), and radiation necrosis (n = 6, 12%).
Conclusions. Linear accelerator-based stereotactic radiosurgery boost within 4 to 6 weeks after whole brain irradiation proved to be an efficacious and well-tolerated treatment strategy for the management of patients with ≥4 brain metastases in our study.

Tumori 2014; 100(3): 302 - 306

Article Type: ORIGINAL RESEARCH ARTICLE

DOI:10.1700/1578.17210

Authors

Ferrat Dincoglan, Omer Sager, Hakan Gamsiz, Bora Uysal, Selcuk Demiral, Kaan Oysul, Sait Sirin, Ayca Caglan, Murat Beyzadeoglu

Article History

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

  • Dincoglan, Ferrat [PubMed] [Google Scholar]
    Department of Radiation Oncology, Gulhane Military Medical Academy, Ankara, Turkey
  • Sager, Omer [PubMed] [Google Scholar]
    Department of Radiation Oncology, Gulhane Military Medical Academy, Ankara, Turkey
  • Gamsiz, Hakan [PubMed] [Google Scholar]
    Department of Radiation Oncology, Gulhane Military Medical Academy, Ankara, Turkey
  • Uysal, Bora [PubMed] [Google Scholar]
    Department of Radiation Oncology, Gulhane Military Medical Academy, Ankara, Turkey
  • Demiral, Selcuk [PubMed] [Google Scholar]
    Department of Radiation Oncology, Gulhane Military Medical Academy, Ankara, Turkey
  • Oysul, Kaan [PubMed] [Google Scholar]
    Department of Radiation Oncology, Gulhane Military Medical Academy, Ankara, Turkey
  • Sirin, Sait [PubMed] [Google Scholar]
    Department of Neurosurgery, Gulhane Military Medical Academy, Ankara, Turkey
  • Caglan, Ayca [PubMed] [Google Scholar]
    Department of Radiation Oncology, Gulhane Military Medical Academy, Ankara, Turkey
  • Beyzadeoglu, Murat [PubMed] [Google Scholar]
    Department of Radiation Oncology, Gulhane Military Medical Academy, Ankara, Turkey

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.